Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

A lawsuit filed by the Federal Trade Commission alleges Evoke Wellness LLC and its management services company used deceptive ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Firefighters uncovered a hidden drug lab while battling a four-alarm blaze in a Bronx apartment building, according to an ...

Alphabet Inc.’s Google has deepened its commitment to artificial intelligence (AI) by investing an additional $1 billion in ...

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...

Verseon, a pioneering company in physics- and AI-powered drug discovery, revealed that its AI technology significantly ...